News
Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?
The initial implementation phase of myUABResearch, the university’s new electronic research administration system, is on ...
New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process.
A review of randomized clinical trials published in rheumatology from 2009 to 2023 found that just 39.8% of authors were women, and that women were less likely to be senior authors, according to data ...
The clinical trials office will build on Manitoba’s strength as Canada’s second-largest pharmaceutical exporter and a hub for ...
The next frontier in clinical development is modelling feasibility and continuous scenario-planning, even amid changing ...
Currently, PET scanner validation phantoms, methods, and acceptance criteria for clinical trials are not standardized. This situation generates substantial inefficiencies with many scanners being ...
While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...
The Nutrition Care Process (NCP) constitutes a systematic methodology that underpins clinical nutrition practice, guiding dietitians through comprehensive patient assessments, diagnosis ...
Automation and artificial intelligence are streamlining everything from regulatory tasks to clinical trials and drug ...
From minimally invasive surgery through robotic technology to regenerative medicine with stem cells, and the increasingly ...
Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results